Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Cancer Cell Analysis Market by Type (Instruments, Consumables, Reagents), By Application (Cancer Research Centers, Cancer Hospital, Surgical Centers, Clinics) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Cancer Cell Analysis Market by Type (Instruments, Consumables, Reagents), By Application (Cancer Research Centers, Cancer Hospital, Surgical Centers, Clinics) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 137781 3300 Medical Devices & Consumables 377 248 Pages 4.5 (31)

Market Overview:

The global cancer cell analysis market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The market growth is attributed to the increasing incidence of cancer, rising demand for personalized medicine, and technological advancements in cancer cell analysis instruments and consumables. Based on type, the global cancer cell analysis market is segmented into instruments, consumables, and reagents. The instruments segment is further divided into flow cytometers, microscopes & slides scanners, Next-Generation Sequencing (NGS) platforms & systems), and other instruments. The consumables segment includes buffers & solutions; antibodies; enzymes; nucleic acids; probes; kits & assays; and others (including software). and others (including software).

Global Cancer Cell Analysis Industry Outlook

Product Definition:

Cancer Cell Analysis is a laboratory technique used to study the genetic makeup and behavior of cancer cells. This information can be used to develop new treatments for cancer and to determine how well a patient is responding to treatment.


Instruments are the core of any cancer research. The most commonly used instruments in oncology are microscopes, cell analyzers, and bioreactors. Cancer researchers have been using these instruments to study tumor cells and their interaction with the body's immune system for many years now.


Consumables and it's usage in Cancer Cell Analysis market include reagents, kits, assay systems, cell lines and culture media. The cancer consumables market is expected to witness significant growth over the forecast period owing to increasing prevalence of cancer globally coupled with rising R&D activities for the development of novel drugs. Moreover growing demand for personalized medicine is also one of the factors driving this industry’s growth.

Application Insights:

The cancer research centers accounted for the largest revenue share in 2017. This is due to an increase in R&D investments by major players for the development of new drugs and therapies against cancer. For instance, in September 2016, Gilead Sciences Inc., a manufacturer of oncology therapeutics, announced that it has invested approximately USD 120 million to expand its presence at Research Park-NGT near Bangalore, India. The expansion project includes construction of a state-of-the-art research facility with advanced facilities for R&D and manufacturing by 2018.

This initiative was taken up after the approval of ¢â‚¬Å“New Drug Application¢â‚¬ (NDA) pertaining to its drug ZINPLAVA (bezlotoxumab) injection 30 mg & 60 mg for multiple myeloma therapy from U.S FDA in June 2016 and October 2015 respectively.

Regional Analysis:

North America dominated the global cancer cell analysis market in 2017. This can be attributed to the presence of a well-established healthcare infrastructure, high adoption of advanced technologies, and government support for research activities. Moreover, increasing incidence rates of various types of cancers are also expected to contribute towards market growth during the forecast period.

Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising investments by major industry players in this region along with growing awareness about these products among patients and physicians. In addition, an increase in disposable income levels is also likely to contribute towards regional demand during the same period due to which many people opt for advanced diagnostic techniques such as flow cytometry devices that require consumables or reagents for use instead of manual procedures thus driving revenue generation opportunities within this region over time (Figure 1).

In 2016, China accounted for a share of more than 20% amongst all Asian countries while India held around 7%.

Growth Factors:

  • Increasing incidence of cancer: The increasing incidence of cancer is the major growth driver for the global cancer cell analysis market. According to the World Health Organization (WHO), in 2012, there were around 14 million new cases of cancer and 8.2 million deaths due to this disease worldwide. This number is expected to increase significantly in the next few years owing to various factors such as aging population, unhealthy lifestyle, and environmental pollution.
  • Rising demand for personalized medicine: The rising demand for personalized medicine is another key growth driver for the global cancer cell analysis market. With advances in technology and growing understanding of tumor biology, physicians are now able to tailor treatments according to each patient’s individual genetic makeup, which has resulted in improved patient outcomes across a range of cancers. This trend is likely to fuel demand for advanced diagnostic tools such as cancer cell analysis platforms in the coming years.
  • Growing investment in R&D: There has been a significant increase in investment by pharmaceutical companies and other research organizations into R&D activities aimed at developing novel therapies and diagnostics for various types of cancers over recent years .This is likely to result in increased adoption of advanced technologies such as Cancer Cell Analysis platforms over the forecast period .

Scope Of The Report

Report Attributes

Report Details

Report Title

Cancer Cell Analysis Market Research Report

By Type

Instruments, Consumables, Reagents

By Application

Cancer Research Centers, Cancer Hospital, Surgical Centers, Clinics

By Companies

Thermo Fisher Scientific, Abbott, Bio-Rad, GE Healthcare, Merck Millipore, QIAGEN, ...

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year


Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year


Number of Pages


Number of Tables & Figures


Customization Available

Yes, the report can be customized as per your need.

Global Cancer Cell Analysis Market Report Segments:

The global Cancer Cell Analysis market is segmented on the basis of:


Instruments, Consumables, Reagents

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.


Cancer Research Centers, Cancer Hospital, Surgical Centers, Clinics

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Thermo Fisher Scientific
  2. Abbott
  3. Bio-Rad
  4. GE Healthcare
  5. Merck Millipore
  7. ...

Global Cancer Cell Analysis Market Overview

Highlights of The Cancer Cell Analysis Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Instruments
    2. Consumables
    3. Reagents
  1. By Application:

    1. Cancer Research Centers
    2. Cancer Hospital
    3. Surgical Centers
    4. Clinics
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Cancer Cell Analysis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Cancer Cell Analysis Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?

Cancer cell analysis is a process that helps doctors determine the type and stage of cancer a person has. It also helps doctors plan treatment.

Some of the major companies in the cancer cell analysis market are Thermo Fisher Scientific, Abbott, Bio-Rad, GE Healthcare, Merck Millipore, QIAGEN.

The cancer cell analysis market is expected to grow at a compound annual growth rate of 10.8%.

1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Cancer Cell Analysis Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Cancer Cell Analysis Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Cancer Cell Analysis Market - Supply Chain
   4.5. Global Cancer Cell Analysis Market Forecast
      4.5.1. Cancer Cell Analysis Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Cancer Cell Analysis Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Cancer Cell Analysis Market Absolute $ Opportunity

5. Global Cancer Cell Analysis Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Cancer Cell Analysis Market Size and Volume Forecast by Type
      5.3.1. Instruments
      5.3.2. Consumables
      5.3.3. Reagents
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Cancer Cell Analysis Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Cancer Cell Analysis Market Size and Volume Forecast by Application
      6.3.1. Cancer Research Centers
      6.3.2. Cancer Hospital
      6.3.3. Surgical Centers
      6.3.4. Clinics
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Cancer Cell Analysis Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Cancer Cell Analysis Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Cancer Cell Analysis Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Cancer Cell Analysis Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Cancer Cell Analysis Demand Share Forecast, 2019-2029

9. North America Cancer Cell Analysis Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Cancer Cell Analysis Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Cancer Cell Analysis Market Size and Volume Forecast by Application
      9.4.1. Cancer Research Centers
      9.4.2. Cancer Hospital
      9.4.3. Surgical Centers
      9.4.4. Clinics
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Cancer Cell Analysis Market Size and Volume Forecast by Type
      9.7.1. Instruments
      9.7.2. Consumables
      9.7.3. Reagents
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Cancer Cell Analysis Demand Share Forecast, 2019-2029

10. Latin America Cancer Cell Analysis Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Cancer Cell Analysis Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Cancer Cell Analysis Market Size and Volume Forecast by Application
      10.4.1. Cancer Research Centers
      10.4.2. Cancer Hospital
      10.4.3. Surgical Centers
      10.4.4. Clinics
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Cancer Cell Analysis Market Size and Volume Forecast by Type
      10.7.1. Instruments
      10.7.2. Consumables
      10.7.3. Reagents
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Cancer Cell Analysis Demand Share Forecast, 2019-2029

11. Europe Cancer Cell Analysis Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Cancer Cell Analysis Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Cancer Cell Analysis Market Size and Volume Forecast by Application
      11.4.1. Cancer Research Centers
      11.4.2. Cancer Hospital
      11.4.3. Surgical Centers
      11.4.4. Clinics
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Cancer Cell Analysis Market Size and Volume Forecast by Type
      11.7.1. Instruments
      11.7.2. Consumables
      11.7.3. Reagents
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Cancer Cell Analysis Demand Share, 2019-2029

12. Asia Pacific Cancer Cell Analysis Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Cancer Cell Analysis Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Cancer Cell Analysis Market Size and Volume Forecast by Application
      12.4.1. Cancer Research Centers
      12.4.2. Cancer Hospital
      12.4.3. Surgical Centers
      12.4.4. Clinics
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Cancer Cell Analysis Market Size and Volume Forecast by Type
      12.7.1. Instruments
      12.7.2. Consumables
      12.7.3. Reagents
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Cancer Cell Analysis Demand Share, 2019-2029

13. Middle East & Africa Cancer Cell Analysis Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Cancer Cell Analysis Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Cancer Cell Analysis Market Size and Volume Forecast by Application
      13.4.1. Cancer Research Centers
      13.4.2. Cancer Hospital
      13.4.3. Surgical Centers
      13.4.4. Clinics
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Cancer Cell Analysis Market Size and Volume Forecast by Type
      13.7.1. Instruments
      13.7.2. Consumables
      13.7.3. Reagents
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Cancer Cell Analysis Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Cancer Cell Analysis Market: Market Share Analysis
   14.2. Cancer Cell Analysis Distributors and Customers
   14.3. Cancer Cell Analysis Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Thermo Fisher Scientific Overview Financials Developments Strategic Outlook
      14.4.2. Abbott Overview Financials Developments Strategic Outlook
      14.4.3. Bio-Rad Overview Financials Developments Strategic Outlook
      14.4.4. GE Healthcare Overview Financials Developments Strategic Outlook
      14.4.5. Merck Millipore Overview Financials Developments Strategic Outlook
      14.4.6. QIAGEN Overview Financials Developments Strategic Outlook
      14.4.7. ... Overview Financials Developments Strategic Outlook
      14.4.8. COMPANY8 Overview Financials Developments Strategic Outlook
      14.4.9. COMPANY9 Overview Financials Developments Strategic Outlook
      14.4.10. COMPANY 10 Overview Financials Developments Strategic Outlook
      14.4.11. COMPANY 11 Overview Financials Developments Strategic Outlook
      14.4.12. COMPANY 12 Overview Financials Developments Strategic Outlook
      14.4.13. COMPANY 13 Overview Financials Developments Strategic Outlook
      14.4.14. COMPANY 14 Overview Financials Developments Strategic Outlook
      14.4.15. COMPANY 15 Overview Financials Developments Strategic Outlook
      14.4.16. COMPANY 16 Overview Financials Developments Strategic Outlook
      14.4.17. COMPANY 17 Overview Financials Developments Strategic Outlook
      14.4.18. COMPANY 18 Overview Financials Developments Strategic Outlook
      14.4.19. COMPANY 19 Overview Financials Developments Strategic Outlook
      14.4.20. COMPANY 20 Overview Financials Developments Strategic Outlook

Our Trusted Clients

Contact Us